Skip to main content
. 2014 Feb 4;52(3):199–215. doi: 10.2486/indhealth.2013-0100

Table 3. Self-reporting work-related respiratory and cardiovascular symptoms developed after employed in nanomaterials handling plants stratified by risk levels.

Variables Prevalence
Self-reporting work-related
Control
(n=200)
Risk Level 1
(n=139)
Risk Level 2
(n=119)
p-value* Control
(n=200)
Risk Level 1
(n=139)
Risk Level 2
(n=119)
p-value*
n (%) n (%) n (%) n % n % n %
Respiratory symptoms (not related to URI)
Dry cough 24 12.1% 19 13.7% 20 16.8% 0.49 3 1.5% 8 5.8% 7 5.9% 0.06
Productive cough 14 7.0% 16 11.6% 11 9.2% 0.35 0 0.0% 3 2.2% 3 2.5% 0.09
Wheezing 4 2.0% 1 0.7% 1 0.8% 0.51 0 0.0% 0 0.0% 1 0.8% 0.24
Chest tightness 20 10.1% 8 5.8% 10 8.4% 0.37 7 3.5% 3 2.2% 4 3.4% 0.76
Shortness of breath 14 7.0% 2 1.5% 3 2.5% 0.02 2 1.0% 1 0.7% 2 1.7% 0.75
Sneezing 35 17.6% 25 18.0% 23 19.3% 0.93 4 2.0% 11 7.9% 7 5.9% 0.04
Rhinitis 22 11.1% 14 10.1% 15 12.6% 0.81 2 1.0% 6 4.3% 3 2.5% 0.15
Nose obstruction 30 15.1% 23 16.6% 21 17.7% 0.83 5 2.5% 7 5.0% 4 3.4% 0.46
Rhinorrhea 30 15.1% 18 13.0% 19 16.0% 0.77 3 1.5% 8 5.8% 5 4.2% 0.10

Cardiovascular symptoms
Chest oppression, pain, burning sensation 10 5.1% 7 5.0% 8 6.7% 0.79 3 1.5% 1 0.7% 3 2.5% 0.50
Chest pain with radiation to left arm, shoulder, chin or back 6 3.0% 5 3.6% 4 3.4% 0.96 4 2.0% 3 2.2% 3 2.5% 0.95
Sweating, nausea, vomiting, dizziness and irritable, in addition to chest pain 5 2.5% 1 0.7% 6 5.1% 0.09 2 1.0% 1 0.7% 4 3.4% 0.16
Unexpected chest pain, without resolve after 10 to 15 min rest 1 0.5% 1 0.7% 7 5.9% <0.001 0 0.0% 1 0.7% 1 0.8% 0.45

*p value for χ2 test